M/15/026 – Baxter Healthcare / Fannin Compounding
Transaction details
The proposed acquisition by Baxter Healthcare Limited of certain assets relating to the medical compounding business of Fannin Limited has been cleared by the Competition and Consumer Protection Commission.
| Notification date | Decision date |
|---|---|
| Tuesday June 9, 2015 | Wednesday, October 21, 2015 |
| Parties Involved | Business activities |
|---|---|
| Baxter Healthcare Limited | Baxter Healthcare is a global healthcare company primarily active in the medical device, pharmaceutical and biotechnology sectors. |
| Fannin Limited | Fannin is a provider of medical devices, medicines, diagnostic products and related services in Ireland. |
| Economic sector | Media merger |
|---|---|
| Pharmaceutical sector. | N/A |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Monday, June 22, 2015 | Monday, September 14, 2015 |
| Date of Requirement for Information | Date Information Received |
|---|---|
| Friday, July 17, 2015 | Friday, July 24, 2015 |
| Current status: Completed |
|---|
| Cleared (Phase 2) |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Barry O'Donnell | Tel: 01-470 3696, e-mail: barryodonnell@ccpc.ie |
Media enquiries: MKC Communications: 01 7038600
Haven’t found what you’re looking for?
Scroll
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555